Drug Shortage Report for ADMELOG

Last updated on 2022-05-25 History
Report ID 161083
Drug Identification Number 02469898
Brand name ADMELOG
Common or Proper name Admelog Cartridge
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) INSULIN LISPRO
Strength(s) 100UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 5 cartridges/box
ATC code A10AB
ATC description INSULINS AND ANALOGUES
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2022-05-18
Estimated end date 2022-05-27
Actual end date 2022-05-24
Shortage status Resolved
Updated date 2022-05-25
Company comments Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2022-05-25 English Compare
v6 2022-05-24 French Compare
v5 2022-05-24 English Compare
v4 2022-05-20 French Compare
v3 2022-05-20 English Compare
v2 2022-05-20 French Compare
v1 2022-05-20 English Compare

Showing 1 to 7 of 7